Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Board of Directors of the Company at its Meeting held on Friday May 20 2022 inter-alia has:
1. Considered and approved the Audited Financial Results for the Quarter and year ended March 31 2022.
2. Recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.
The Financials Results will be published in newspapers as required under the Listing Regulations.
The Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 04:30 p.m.
Supriya Lifescience: Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
May 20, 2022
Download PDF
Supriya Lifescience
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month